• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

High molecular weight kininogen deficiency: a patient who underwent cardiac surgery.

作者信息

Davidson S J, Burman J F, Rutherford L C, Keogh B F, Yacoub M H

机构信息

Department of Haematology, Royal Brompton Hospital, London, UK.

出版信息

Thromb Haemost. 2001 Feb;85(2):195-7.

PMID:11246531
Abstract

A 66 year old male, referred for cardiac surgery, was found to have high molecular weight kininogen deficiency (activity <1%). Apart from activated partial thromboplastin time (APTT) >300 s, tests of haemostasis were otherwise normal (factors VIII, IX, XI, XII and prekallikrein). No inhibitor of coagulation was found. The activated coagulation time (ACT) was 800 s pre-operatively and >1000 s after heparin. Heparin levels were measured directly by an anti-Xa chromogenic assay, with values of between 2.9 and 3.2 u/ml during cardiopulmonary bypass. Thrombin-antithrombin levels rose from 2.3g/l before surgery to a peak of 83.5g/l at the end of cardiopulmonary bypass. Cross linked fibrin d-dimers (XDP) levels rose from 100 ng/ml before operation to 600 ng/ml after protamine administration. The patient had no excess bleeding and no thrombotic complications from surgery. This patient shows that high molecular weight kininogen is not required for thrombin formation or fibrinolysis during cardiac surgery and illustrates the need to measure heparin directly in patients with such contact factor deficiencies.

摘要

相似文献

1
High molecular weight kininogen deficiency: a patient who underwent cardiac surgery.
Thromb Haemost. 2001 Feb;85(2):195-7.
2
Contact factor deficiencies and cardiopulmonary bypass surgery: detection of the defect and monitoring of heparin.接触因子缺乏与体外循环手术:缺陷的检测及肝素监测
Eur J Haematol. 2009 Mar;82(3):208-12. doi: 10.1111/j.1600-0609.2008.01191.x. Epub 2008 Dec 5.
3
Practical approach to anticoagulation for cardiopulmonary bypass in the patient with congenital prolonged activated partial thromboplastin time.
Blood Coagul Fibrinolysis. 2008 Oct;19(7):725-6. doi: 10.1097/MBC.0b013e32830891ab.
4
Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.心脏手术后活化部分凝血活酶时间升高与肝素反跳无关。
Can J Anaesth. 2009 Jul;56(7):489-96. doi: 10.1007/s12630-009-9098-6. Epub 2009 May 2.
5
Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.心脏手术体外循环中的抗凝与抗凝逆转:最新进展
J Cardiothorac Vasc Anesth. 1999 Aug;13(4 Suppl 1):18-29; discussion 36-7.
6
Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.体外循环期间高剂量肝素化监测——凝血酶原酶诱导凝血时间(PiCT)与两种发色底物法抗Xa因子活性测定的比较
Thromb Haemost. 2008 Feb;99(2):427-34. doi: 10.1160/TH07-04-0307.
7
Activated coagulation and activated partial thromboplastin times in assessment and reversal of heparin-induced anticoagulation for cardiopulmonary bypass.在体外循环肝素诱导抗凝的评估及逆转过程中活化凝血时间和活化部分凝血活酶时间的应用
Anesth Analg. 1983 Aug;62(8):710-9.
8
Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.监测肝素与抑肽酶联合应用时的活化凝血时间:使用Sonoclot对一种新型抑肽酶不敏感检测方法的体内评估
Eur J Cardiothorac Surg. 2006 Aug;30(2):278-84. doi: 10.1016/j.ejcts.2006.05.016. Epub 2006 Jul 7.
9
Hemofiltration removes bradykinin generated in the priming blood in cardiopulmonary bypass during circulation.血液滤过可清除体外循环期间预充血液中产生的缓激肽。
Ann Thorac Cardiovasc Surg. 1998 Apr;4(2):59-63.
10
The monitoring of heparin administration by screening tests in experimental dogs.通过筛选试验对实验犬肝素给药进行监测。
Res Vet Sci. 2001 Apr;70(2):101-8. doi: 10.1053/rvsc.2000.0447.

引用本文的文献

1
The First Korean Case of High-Molecular-Weight Kininogen Deficiency, With a Novel Variant, c.488delG, in the Gene.首例韩国人高分子量激肽原缺乏症病例,该基因存在一种新的变异,即c.488delG。
Ann Lab Med. 2020 May;40(3):264-266. doi: 10.3343/alm.2020.40.3.264.
2
The Effects of the Contact Activation System on Hemorrhage.接触激活系统对出血的影响。
Front Med (Lausanne). 2017 Jul 31;4:121. doi: 10.3389/fmed.2017.00121. eCollection 2017.
3
Do children without a known bleeding tendency undergoing PICC placement require coagulation laboratory testing?
接受经外周静脉穿刺中心静脉置管(PICC)的无已知出血倾向的儿童需要进行凝血实验室检查吗?
Pediatr Radiol. 2015 Apr;45(5):727-35. doi: 10.1007/s00247-014-3207-6. Epub 2015 Feb 6.
4
Isolated APTT prolongation-not always a bleeding risk in acute paediatric burns surgery.孤立性活化部分凝血活酶时间延长——在小儿急性烧伤手术中并不总是出血风险因素
Eur J Plast Surg. 2014;37(12):695-696. doi: 10.1007/s00238-014-1012-y. Epub 2014 Sep 5.
5
Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain barrier damage, and inflammation.激肽原缺乏通过减少血栓形成、血脑屏障损伤和炎症来保护小鼠免受缺血性神经退行性变。
Blood. 2012 Nov 8;120(19):4082-92. doi: 10.1182/blood-2012-06-440057. Epub 2012 Aug 30.
6
Heparin anticoagulation in patients undergoing off-pump and on-pump coronary bypass surgery.非体外循环和体外循环冠状动脉搭桥手术患者的肝素抗凝治疗。
J Anesth. 2007;21(3):297-303. doi: 10.1007/s00540-007-0506-1. Epub 2007 Aug 1.